Literature DB >> 30140962

Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.

Janice S Sung1, Adriana D Corben2,3, Jennifer D Brooks4, Marcia Edelweiss2, Delia M Keating1, Christine Lin5, Elizabeth A Morris1, Prusha Patel5, Mark Robson6, Meghan Woods5, Jonine L Bernstein5, Malcolm C Pike7.   

Abstract

PURPOSE: Breast fibroglandular tissue (FGT), as visualized on a mammogram (mammographic density, MD), is one of the strongest known risk factors for breast cancer. FGT is also visible on breast MRI, and increased background parenchymal enhancement (BPE) in the FGT has been identified as potentially a major breast cancer risk factor. The aim of this exploratory study was to examine the biologic basis of BPE.
METHODS: We examined the unaffected contra-lateral breast of 80 breast cancer patients undergoing a prophylactic mastectomy before any treatment other than surgery of their breast cancer. BPE was classified on the BI-RADS scale (minimal/mild/moderate/marked). Slides were stained for microvessel density (MVD), CD34 (another measure of endothelial density), glandular tissue within the FGT and VEGF. Spearman correlations were used to evaluate the associations between BPE and these pathologic variables.
RESULTS: In pre-menopausal patients, BPE was highly correlated with MVD, CD34 and glandular concentration within the FGT, and the pathologic variables were themselves highly correlated. The expression of VEGF was effectively confined to terminal duct lobular unit (TDLU) epithelium. The same relationships of the four pathologic variables with BPE were seen in post-menopausal patients, but the relationships were much weaker and not statistically significant.
CONCLUSION: The strong correlation of BPE and MVD together with the high correlation of MVD with glandular concentration seen in pre-menopausal patients indicates that increased breast cancer risk associated with BPE in pre-menopausal women is likely to result from its association with increased concentration of glandular tissue in the FGT. The effective confinement of VEGF expression to the TDLUs shows that the signal for MVD growth arises directly from the glandular tissue. Further studies are needed to understand the basis of BPE in post-menopausal women.

Entities:  

Keywords:  Background parenchymal enhancement; Breast MRI; Fibroglandular tissue; Immunohistochemistry; Microvessel density; VEGF

Mesh:

Year:  2018        PMID: 30140962      PMCID: PMC6697118          DOI: 10.1007/s10549-018-4916-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

Review 1.  Background parenchymal enhancement on breast MRI: A comprehensive review.

Authors:  Geraldine J Liao; Leah C Henze Bancroft; Roberta M Strigel; Rhea D Chitalia; Despina Kontos; Linda Moy; Savannah C Partridge; Habib Rahbar
Journal:  J Magn Reson Imaging       Date:  2019-04-19       Impact factor: 4.813

2.  Background parenchymal enhancement in contrast-enhanced MR imaging suggests systemic effects of intrauterine contraceptive devices.

Authors:  Luisa Charlotte Huck; Daniel Truhn; Caroline Wilpert; Eloisa Zanderigo; Vanessa Raaff; Ebba Dethlefsen; Maike Bode; Christiane Katharina Kuhl
Journal:  Eur Radiol       Date:  2022-05-07       Impact factor: 5.315

3.  The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation.

Authors:  Carolyn L Westhoff; Hua Guo; Zhong Wang; Hanina Hibshoosh; Margaret Polaneczky; Malcolm C Pike; Richard Ha
Journal:  Breast Cancer Res Treat       Date:  2022-01-11       Impact factor: 4.624

4.  High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy.

Authors:  Chuanhui Xu; Jinhui Yu; Feifei Wu; Xuemei Li; Dongmin Hu; Guiming Chen; Gang Wu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

5.  Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker.

Authors:  Rossella Rella; Andrea Contegiacomo; Enida Bufi; Sara Mercogliano; Paolo Belli; Riccardo Manfredi
Journal:  Br J Radiol       Date:  2020-10-15       Impact factor: 3.039

6.  Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI.

Authors:  Ga Eun Park; Sung Hun Kim; Eun Byul Lee; Yoonho Nam; Wonmo Sung
Journal:  Tomography       Date:  2022-03-01

7.  Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2- Patients.

Authors:  Vignesh A Arasu; Paul Kim; Wen Li; Fredrik Strand; Cody McHargue; Roy Harnish; David C Newitt; Ella F Jones; M Maria Glymour; John Kornak; Laura J Esserman; Nola M Hylton
Journal:  J Breast Imaging       Date:  2020-07-22

Review 8.  Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy.

Authors:  Ella F Jones; Deep K Hathi; Rita Freimanis; Rita A Mukhtar; A Jo Chien; Laura J Esserman; Laura J Van't Veer; Bonnie N Joe; Nola M Hylton
Journal:  Cancers (Basel)       Date:  2020-06-09       Impact factor: 6.575

9.  The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI.

Authors:  Roxanna Hellgren; Ariel Saracco; Fredrik Strand; Mikael Eriksson; Ann Sundbom; Per Hall; Paul W Dickman
Journal:  Acta Radiol       Date:  2020-03-26       Impact factor: 1.990

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.